SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001013594-18-000050
Filing Date
2018-01-18
Accepted
2018-01-18 17:28:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUARY 18, 2018 anthera13g-011818.htm SC 13G 79240
  Complete submission text file 0001013594-18-000050.txt   80746
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Subject) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85368 | Film No.: 18534833
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE SUITE 2205 NEW YORK NY 10019 (212) 554-2379
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G